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Background: Poor sleep is prevalent in patients with systemic inflammatory disorders, including rheumatoid
arthritis, and, in addition to fatigue, pain, depression and inflammation, is associated with an increased risk of
co-morbidity and all-cause mortality. Whereas non-pharmacological interventions in patients with rheumatoid
arthritis have been shown to reduce pain and fatigue, no randomized controlled trials have examined the effect of
non-pharmacological interventions on improvement of sleep in patients with rheumatoid arthritis. The aim of this
trial was to evaluate the efficacy of an intermittent aerobic exercise intervention on sleep, assessed both objectively
and subjectively in patients with rheumatoid arthritis.
Methods/design: A randomized controlled trial including 44 patients with rheumatoid arthritis randomly assigned
to an exercise training intervention or to a control group. The intervention consists of 18 session intermittent
aerobic exercise training on a bicycle ergometer three times a week. Patients are evaluated according to objective
changes in sleep as measured by polysomnography (primary outcome). Secondary outcomes include changes in
subjective sleep quality and sleep disturbances, fatigue, pain, depressive symptoms, physical function, health-related
quality of life and cardiorespiratory fitness.
Discussion: This trial will provide evidence of the effect of intermittent aerobic exercise on the improvement of
sleep in patients with rheumatoid arthritis, which is considered important in promotion of health and well-being.
As such, the trial meets a currently unmet need for the provision of non-pharmacological treatment initiatives of
poor sleep in patients with rheumatoid arthritis.
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Restorative sleep has an important role in maintaining
health [1], with disrupted or lower levels of sleep being
related to serious outcomes such as increased risk of
morbidities [2,3] and ultimately all-cause mortality [4].
Sleep disturbances and poor sleep quality are prevalent
complaints in patients with chronic diseases [5] includ-
ing rheumatoid arthritis (RA). RA is a chronic inflam-
matory disease associated with increased mortality, high
morbidity and reduced health related quality of life [6,7].
It affects between 0.1 and 0.5% of adults in developed
countries and is three times more frequent in women
than men. In addition to pain and fatigue, poor sleep has
been identified as a major concern by patients with RA
[8] affecting 50-70% of the patients [9]. Importantly,
poor sleep in RA may be affected by pain or may con-
tribute to increased pain and fatigue [10-13], and is asso-
ciated with depression [14,15] and inflammation [16].
Thus, addressing poor sleep quality may be important in
promoting health and well-being in patients with RA.
Few studies have examined treatments for managing
poor sleep in patients with RA. Those carried out have
examined sleep medication (eszopiclone, zopiclone, val-
erian) [17-19] or biological therapies (tocilizumab, inflix-
imab, anti-tumor necrosis factor α, abatacept) [20-23].
However, non-pharmacological psychological interven-
tions (e.g. cognitive behavioral therapy) [24] have been
shown to be an effective alternative for patients with
sleep disturbances and may have a longer-lasting effect,
with no side effects. However, psychological interven-
tions (e.g. cognitive behavioral therapy) typically require
highly skilled clinicians and may therefore be expensive
and time-intensive to deliver [24]. Also, while psycho-
logical interventions are promising, they mainly affect
mental health and/or include low-intensity behavioral
interventions (e.g. relaxation) with little or no effect on
functional and physiological outcomes.
Cross-sectional studies have shown that physical inactiv-
ity increases the likelihood of reporting poor sleep, even
after controlling for age, depression and pain [25,26]. Fur-
thermore, it has been reported that, independent of age
and sex [27], maximal aerobic capacity is lower in patients
with insomnia compared to those without it. In addition,
physical exercise interventions have been shown to be a
feasible and effective non-pharmacological treatment mo-
dality for improving sleep in healthy and in clinical popula-
tions [28-31]. Exercise interventions is known to improve
cardiorespiratory fitness, muscle strength and functional
ability [32], as well as health-related quality of life [33], and
to reduce co-morbidity [34] in patients with RA. Thus,
physical exercise interventions may be a viable non-
pharmacological alternative for both prevention and treat-
ment of poor sleep in addition to the simultaneous benefits
for numerous health parameters in the human body.The effect of physical exercise interventions on poor
sleep has not hitherto been examined in patients with RA.
However, a systematic review including older adults has
shown that exercise of moderate intensity has a moderately
positive effect on improvement of self-reported sleep [31].
In addition, a randomized controlled trial (RCT) [35] of
adults > 55 years old found that moderate intensity exercise
decreased objectively measured Stage 1 sleep and number
of nighttime awakenings, and increased Stage 2 sleep. How-
ever, high-intensity aerobic exercise may also be assumed
to be efficient for improving sleep. For patients who do not
possess the necessary fitness level to perform continuous
high-intensity exercise, aerobic intermittent training (de-
fined as: vigorous exercise performed at a high intensity for
a brief period of time interposed with recovery intervals at
low to moderate intensity [36]), may provide an alternative
to continuous high-intensity exercise.
In summary, the significant morbidity associated with
poor sleep and the multifactorial impact of physical exercise
suggest that an intermittent aerobic exercise training inter-
vention may constitute a promising non-pharmacological
treatment approach for the management of poor sleep in
patients with RA.
Against this background, the aim of this trial is to assess
the efficacy of an aerobic intermittent exercise training
intervention on sleep quality and sleep disturbances in pa-
tients with RA. The primary hypothesis is that intermit-
tent aerobic exercise will be superior to no exercise in the
improvement of objectively measured sleep. The second-
ary hypotheses are that patients randomly assigned to the
exercise intervention will show greater improvement in
subjective sleep quality and sleep disturbances, cardiore-
spiratory fitness, and physical function as well as reduced
pain, fatigue and depressive symptoms and improved
health-related quality of life compared to patients ran-
domly assigned to the no-intervention (control group).
Methods
Design
The present RCT is single blinded, with an aerobic inter-
mittent exercise training intervention and a primary
endpoint of sleep measured by polysomnography (PSG).
Flow of patients through the trial is shown in Figure 1.
Sample size
The sample size calculation is based on the sleep compo-
nent `sleep efficiency´. A previous RCT [37], using PSG as
measurement of sleep, examined the effect of a non-
pharmacological intervention (cognitive behavioral ther-
apy) on sleep disturbances in patients with insomnia and
found a mean sleep efficiency of 81.4% (SD 7.4). The nor-
mal value for sleep efficiency is >85%. Thus the aim for
the patients in the exercise intervention was to achieve a
sleep efficiency of at least 86%. On this basis, and with a
Figure 1 Flow of patients through the randomized controlled trial.
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mated that 36 patients should take part in this trial. A
drop-out rate of 20% is expected, which means that 44 pa-
tients are included, of which 22 are randomly assigned to
the intervention group and 22 to the control group.
Population
The trial consists of 44 patients with a clinical diagno-
sis of RA based on The American College of Rheumatol-




Patients are eligible to participate if they are aged 18-70;
have a diagnosis of RA; report poor sleep quality(Pittsburgh Sleep Quality Index (PSQI) global score >5),
have low disease activity score on 28 joints (DAS28) <3.2,
have a normal 12-lead Electrocardiogram (ECG) and
understand Danish.Exclusion criteria
Patients are excluded if they have documented sleep
apnea (Apnea-Hypopnea Index (AHI) >15/hour); have
night work during the period in which the intervention
takes place; are pregnant or are breast-feeding, are being
treated with steroids, hypnotics, antidepressants or anti-
psychotics, have cardiac symptoms corresponding to
New York Heart Association (NYHA) Functional Classi-
fication >2; are regularly physically active (self-reported
aerobic exercise >3 times per week).
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The patients are recruited from the Rheumatology out-
patient clinics at two Copenhagen University Hospitals,
Glostrup and Frederiksberg, in the Capital Region of
Denmark. Potentially eligible patients receive written in-
formation by mail or are contacted in the outpatient
clinics at Glostrup and Frederiksberg Hospital and receive
a telephone call a few days later. If the patients are inter-
ested in participating in the trial, a telephone screening is
conducted using the PSQI to clarify whether they fulfill
the criteria for poor sleep (PSQI global score >5).
Screening
Eligible patients are screened for sleep apnea. This
screening is performed by cardio-respiratory monitoring
(CRM) consisting of electromyography of the tibialis an-
terior muscles, and electrocardiogram including chan-
nels of digital oximetry, nasal pressure and respiratory
movements (Xtrace thoracic and abdominal straps). Pa-
tients with moderate to severe sleep apnea, AHI >15/
hour, are excluded from the trial, and are referred to the
Center for Sleep Medicine for treatment for sleep apnea.
Safety: During the screening period, to ensure that
their health permits high-intensity intermittent aerobic
training, the patients are asked, by means of a structured
screening instrument, about their heart and lung func-
tion to ensure that they have no symptoms and no limi-
tations on ordinary physical activity, e.g. shortness of
breath when walking, climbing stairs etc. or mild short-
ness of breath and/or angina. Furthermore, the patients
will have had an ECG taken to ensure the safety of par-
ticipating in the aerobic intermittent training program.
Randomization and blinding
Included patients are randomly assigned to one of the
two following conditions: aerobic intermittent training
(n = 22) or control group (n = 22). Randomization is per-
formed by computer-generated `random numbers´ with
a 1:1 allocation ratio. Evaluation of primary outcome is
performed by experienced polysomnographic technicians
who are blinded to group allocation.Table 1 Exercise training program for patients randomized to
18 sessions of aerobic intermittent training (6 – 8 weeks duration)
Session 1 – 6 S
Duration 20 minutes aerobic intermittent training including
5 minute warm-up and cool-down
D
Bock 1 (5 min) Continuous exercise 55-60% Wmax (70-80% HR) B
Block 2 (5 min) Intermittent training
3 x 60 -30 sec.
70-80% Wmax (80-90% HR) B
Block 3 (5 min) Intermittent training
3 x 60-30 sec.
70-80% Wmax (80-90% HR) B
Block 4 (5 min) Continuous exercise 55-60% Wmax (70-80% HR) B
Wmax = watt max, HR = Heart rate.Intervention
The intervention consists of a total of 18 aerobic intermit-
tent training sessions (20-30 minutes/session) spread over
a maximum of eight weeks (2-3 times/week) as shown in
Table 1. The training sessions are performed on bicycle er-
gometers (Kettler) and supervised by trained physiothera-
pists. Each session is initiated by a 5-minute warm-up
period, followed by 4 blocks of 5-7.5 minutes alternating
periods of continuous moderate intensity (40-50% watt
max) and periods of intermittent high-intensity aerobic
exercise (70-80% watt max) [38] and finally a 5-minute
cool-down period. Exercise workload (watt) is determined
individually by a watt max test at baseline, and calculated
from the maximum load reached adjusted for the number
of seconds performed at the highest load. The goal of the
intervention is for each patient to attend at least 14 out of
the 18 planned exercise sessions.
Monitoring
For each exercise session any changes in the prescribed
exercise intensity (watt) is noted. Patients’ heart rate
(Polar) is monitored and noted for each training block,
and the overall mean and maximum heart rate are regis-
tered after each session. In addition, the patients’ rated
perceived exertion is recorded using the Borg Scale
(6-20 rating).
Control group
The control group receives no exercise intervention dur-
ing the test period and is encouraged to maintain a nor-
mal everyday life.
Trial endpoints
Data collection Objective physiological as well as pa-
tient reported outcomes are collected at baseline and at
the end of the intervention (6- 8 weeks).
Assessment of primary endpoint
The primary outcome of the trial is changes in sleep as
measured objectively by PSG at baseline and at the end
of the intervention. PSG measurements are performed at18 sessions of aerobic intermittent training
ession 7 - 18
uration 30 minutes aerobic intermittent training including
5 minute warm-up and cool-down
lock 1 (7.5 min) Continuous exercise 55-60% Wmax (70-80% HR)
lock 2 (7.5 min) Intermittent training
4 x 60 -30 sec.
70-80% Wmax (80-90% HR)
lock 3 (7.5 min) Intermittent training
5 x 60 - 30 sec.
70-80% Wmax (80-90% HR)
lock 4 (7.5 min) Continuous exercise 55-60% Wmax (70-80% HR)
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surroundings. However, the primary investigator per-
forms electrode placement and tests the equipment at
Glostrup Hospital. Sleep monitoring is performed using
Trackit™ Ambulatory EEG (Lifelines Ltd, 7 Clarendon
Court, Over Wallop, Nr. Stockbridge, Hants, UK). The
evaluation of the PSG measurements is performed
following the guidelines of the American Academy of
Sleep Medicine (AASM standard) 2007 [39].Assessment of secondary endpoints
Objective physiological measures
Cardiorespiratory fitness The patients’ cardiorespiratory
fitness is assessed by an incremental maximum work test
on a bicycle ergometer as described by Andersen et al
[40]. The test is modified to accommodate the patients’ fit-
ness level in order to obtain a test period of 5 minutes or
more. Following a 5-minute warm-up period on individual
steady state work intensity the work load increases by 20
watt each minute until exhaustion is reached. Maximum
work load (Watt), maximum heart rate (beats per minute)
and time to exhaustion are recorded as test results. This
test has been shown in previous studies to be suitable
when estimating cardiorespiratory fitness in patients with
chronic disease [41].Plasma
C-reactive protein (CRP) and hemoglobin are assessed at
baseline and at the end of the intervention. If Anti-CCP
and IgM rheumatoid factor are not available these blood
samples will also be taken. In addition, blood pressure,
weight and height will be measured.Disease activity
Disease Activity Score (DAS28) is calculated from the
number of swollen and tender joints (28 joints), CRP
and the patients’ global assessment of how much arth-
ritis affects their lives.Patient reported outcomes The trial includes six stan-
dardized validated questionnaires assessing changes in
patient-reported outcomes.Sleep quality and sleep disturbances
The Pittsburgh Sleep Quality Index (PSQI) [42] mea-
sures self-reported sleep quality and disturbances during
the previous four weeks. PSQI has 19 items and mea-
sures 7 components of sleep: subjective sleep quality,
sleep latency, sleep duration, sleep disturbance, use of
sleeping medication, habitual sleep efficiency and day-
time dysfunction.Sleepiness
The Epworth Sleepiness Scale (ESS) [43] is a self-reported
questionnaire that measures daytime sleepiness. The ques-
tionnaire consists of 8 items with a respondents format
0 =would never doze, 1 = slight chance of dozing, 2 =mod-
erate chance of dozing, and 3 = high chance of dozing.
Sleep pattern
Patients complete sleep diaries for 14 days after each
PSG measurement in order to monitor and describe po-
tential changes in their sleep. The sleep diary contains
self-reported information about what time they go to
bed and get up, as well as the number of awakenings
during the night and daytime dysfunction.
Fatigue
The Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional
Questionnaire (BRAF MDQ) [44] consists of 20 items in-
cluding four sub-scale scores of physical fatigue, living
with fatigue, cognitive fatigue and emotional fatigue. The
questionnaire consists of four options; “not at all”, “a lit-
tle”, “quite a bit”, “very much”.
Depression
The Center for Epidemiological Studies-Depression
(CES-D) [45] consists of 20 items evaluating depressive
symptomatology and attitudes. The patients indicate
how often, over the previous week, they had experi-
enced each of the 20 symptoms on a scale ranging from
0 to 3: rarely or none of the time; some or a little of the
time; occasionally or a moderate amount of the time;
most or all of the time.
Physical function
The Health Assessment Questionnaire (HAQ) [46], in-
cludes 20 items to assess activity limitation in 8 dimen-
sions of activities of daily living: dressing and grooming,
arising, eating, walking, hygiene, reach, grip, and com-
mon daily activities. In addition, in the HAQ question-
naire there is also a Visual Analogue Scale (VAS) for
pain, fatigue and patient global assessment indicating
how much arthritis affects their lives.
Health-related quality of life
EuroQol (EQ-5D-5 L) [47] measures health-related qual-
ity of life. The questionnaire contains five dimensions:
mobility, self-care, usual activities, pain/discomfort and
depression/anxiety. Each dimension has five levels: ‘no
problems’, ‘slight problems’, ‘moderate problems’, ‘severe
problems’ and ‘extreme problems’.
Health status and behavior
Information about self-reported co-morbidity, age, gen-
der, education, work, income, physical activity, smoking,
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Patients are also asked for information about current
medical treatment.
Statistical analyses
Continuous variables, i.e., sleep, cardiorespiratory fitness,
physical function, pain, fatigue, depressive symptoms
and health-related quality of life will be presented as
either means with corresponding 95% confidence limits
or as medians and interquartile range (IQR). The pri-
mary and secondary endpoints will be reported as a two-
sample t-test comparing change scores in the two ran-
domized groups. The primary outcome variables in the
regression model will be sleep parameters. The regres-
sion model will allow control for the baseline value of
the trial endpoints and other confounding variables that
may impact changes in sleep parameters (e.g. age and
gender). Categorical data, i.e., single questionnaire items,
will be reported as proportions and compared across
randomized groups using chi-squared tests or logistic re-
gression. Significance level will be set at 0.05. All tests
will be two-tailed. The primary analysis will compare
changes in the intervention vs. the control group using
the intention-to-treat principle including all available
data. Missing observations will be handled according
to the missing at random assumption. The secondary
analysis will include only patients attending at least 14
exercise sessions (80%) out of the prescribed 18 (i.e. per
protocol analysis). Finally, correlations will be performed
to examine the dose-response relation between changes
in the primary outcome (sleep) and cardiorespiratory fit-
ness. Data entry will be undertaken using a secure web
server and statistical analysis will be performed using
Statistical Analysis Systems (SAS) version 9.3.
Qualitative investigation and methods
Qualitative, semistructured interviews will be held with
purposefully selected sample of patients from the inter-
vention group. These interviews will highlight patients’
experience with intermittent aerobic exercise including
potential changes in pain, fatigue and sleep.
Ethical considerations and confidentiality
The trial follows international ethical guidelines of in-
formed consent in clinical trials. Patients receive written
and verbal information about the trial to ensure they are
able to give informed consent. Participation is voluntary
and patients can withdraw their consent at any time dur-
ing the trial with no consequences for their treatment.
Research ethics approval to conduct this trial was ob-
tained though the Regional Ethics Committee (Journal
No. H-1-2012-151) and the trial has been registered in
www.clinicaltrials.gov (NCT01966835). The trial is ap-
proved by the Danish Data Protection Agency (Ref. No.711-1-08). All information collected during the course
of the trial is kept confidential in accordance with
Danish Data Protection Agency rules.Discussion
The present trial will contribute with empirical evidence
to the field of exercise and sleep that is currently charac-
terized by premature empirical results but with signifi-
cant potential as a non-pharmacological approach for
improving sleep and with several aspects beneficial to
health. The mechanisms of how physical exercise may
reduce poor sleep are yet unknown. One hypothesis may
be that sleep decrease symptoms of depression [48], an-
other is that exercise engages with the two-process
model of circadian and homeostatic regulation [49] or
stimulates the restorative function during sleep and trig-
gers an increase in body temperature [50,51]. The post-
exercise drop in temperature may promote sleep onset
latency and slow-wave sleep.
The present trial is superior to others within the field of
exercise and sleep in three ways. Firstly, we have chosen
the golden standard method for measuring sleep (i.e.
PSG). In comparison, the majority of previous studies with
the aim of improving sleep through physical exercise inter-
ventions have relied on self-reported instruments such as
PSQI and only one trial has used polysomnographic as-
sessment to measure sleep objectively [35].
Secondly, whereas current exercise trials typically apply
continuous moderate intensity aerobic exercise training,
we have chosen to apply aerobic intermittent training.
While regular continuous aerobic exercise is known to im-
prove a wide range of health outcomes, including cardio-
respiratory fitness in both healthy people and clinical
populations, aerobic intermittent training of shorter dur-
ation may result in an equal or superior improvement in
fitness [36].
Finally, this is the first trial within the field of RA to
evaluate the effect of aerobic intermittent training on
improvement in sleep quality and sleep disturbances.
The detailed information collected in this trial regarding
the exact completed adherence to the exercise regime
(including intensity (watt) as well as pulse monitoring
during each training block and interval, and objective
measured sleep duration, sleep stages, and sleep quality)
is expected to provide important experimental results
that can contribute with evidence of both aerobic inter-
mittent training and poor sleep, including causal interac-
tions between the two.Trial status
At the time of manuscript submission the patients are
being recruited to the trial.
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